Technical Analysis for DVA - DaVita HealthCare Partners Inc.

Grade Last Price % Change Price Change
C 162.87 0.91% 1.47
DVA closed up 2.82 percent on Wednesday, November 20, 2024, on 1.2 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.91%
Morning Star Bullish 0.91%
Pocket Pivot Bullish Swing Setup 0.91%
Multiple of Ten Bullish Other 0.91%
Overbought Stochastic Strength 0.91%
50 DMA Resistance Bearish 3.75%
MACD Bullish Centerline Cross Bullish 3.75%
Overbought Stochastic Strength 3.75%
Gapped Down Weakness 3.75%
Fell Below 50 DMA Bearish 3.47%

   Recent Intraday Alerts

Alert Time
Up 1% 3 minutes ago
Rose Above Previous Day's High 10 minutes ago
Up 2% about 23 hours ago
60 Minute Opening Range Breakout about 23 hours ago
Rose Above 50 DMA about 23 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

DaVita HealthCare Partners Inc. Description

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. It primarily operates kidney dialysis centers; and provides acute inpatient dialysis and related lab services primarily in dialysis centers and contracted hospitals. The company offers outpatient, home-based, and hospital inpatient hemodialysis services; ESRD laboratory services; and operates or provides management and administrative services to outpatient dialysis centers that are minority owned by the company or wholly owned by third parties. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; infusion therapy services; disease management services; vascular access services; ESRD clinical research programs; and physician services, as well as manages and operates medical groups and physician networks in California, Nevada, Florida and New Mexico. As of December 31, 2012, it operated or provided administrative services through 1,954 outpatient dialysis centers in 44 states in the United States and the District of Columbia. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.


Classification

Sector: Healthcare
Industry: Medical Care
Keywords: S&P 500 Medicine Clinical Medicine Disease Clinical Research Dialysis Membrane Technology End Stage Renal Disease Hemodialysis Renal Disease Laboratory Services Stage Renal Disease Therapy Services Vascular Access Products Nephrology Renal Dialysis Disease Management Kidney Dialysis Kidney Failure Medical Groups Rockwell Medical Disease Management Services Lab Services Physician Services Infusion Therapy

Is DVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 168.5
52 Week Low 98.26
Average Volume 833,050
200-Day Moving Average 142.77
50-Day Moving Average 158.14
20-Day Moving Average 152.79
10-Day Moving Average 156.03
Average True Range 4.65
RSI (14) 58.33
ADX 16.63
+DI 30.04
-DI 22.28
Chandelier Exit (Long, 3 ATRs) 150.31
Chandelier Exit (Short, 3 ATRs) 151.94
Upper Bollinger Bands 166.45
Lower Bollinger Band 139.12
Percent B (%b) 0.82
BandWidth 17.88
MACD Line 0.55
MACD Signal Line -0.79
MACD Histogram 1.3457
Fundamentals Value
Market Cap 14.74 Billion
Num Shares 91.3 Million
EPS 6.44
Price-to-Earnings (P/E) Ratio 25.06
Price-to-Sales 0.85
Price-to-Book 8.37
PEG Ratio 0.44
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 168.95
Resistance 3 (R3) 168.27 165.08 167.69
Resistance 2 (R2) 165.08 163.16 165.42 167.27
Resistance 1 (R1) 163.24 161.97 164.16 163.92 166.85
Pivot Point 160.05 160.05 160.51 160.39 160.05
Support 1 (S1) 158.21 158.13 159.13 158.89 155.95
Support 2 (S2) 155.02 156.94 155.36 155.53
Support 3 (S3) 153.18 155.02 155.11
Support 4 (S4) 153.86